Interestingly, Ehrenreich et al. has previously demonstrated that infusion with another antioxidant, human erythropoietin (EPO), the hematopoietic growth factor that induces the production of RBC, reduces cognitive deficits in patients with schizophrenia42. This evidence concerns the gene EPO and Cognitive impairment.